The roll out of China’s expanded centralized procurement scheme is underway, including over two dozen provinces and some of the largest pharma markets in China, and involving huge volumes of products.
In a notice posted on its website, the Shanghai Procurement Administration, the general coordinator of the original “4+7” pilot scheme, announced the kick-off of the new
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?